← Back to patent-cliff list
Cetirizine Amidine Sodium
Tier C — Watch / tradeCetirizine Amidine Sodium
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：PBPs
Indications (approved)：Community-acquired pneumonia
Regional status
US
-
EU
-
China
Phase II
2024-11-11
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Cetirizine Amidine Sodium?
Approved indications include: Community-acquired pneumonia.
When does the Cetirizine Amidine Sodium patent expire?
No public expiry year is available for Cetirizine Amidine Sodium yet; this page updates once verified.
How do I get a quote for Cetirizine Amidine Sodium intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-01